Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Optimal Method for Screening and Diagnosis of Gestational Diabetes? An RCT to Evaluate Incidence, Cost-Effectiveness and Clinical Outcomes Using Three Methods

NCT00295659 is registered in ClinicalTrials.gov with Canadian Diabetes Association as lead sponsor.

NCT NCT00295659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Optimal Method for Screening and Diagnosis of Gestational Diabetes? An RCT to Evaluate Incidence, Cost-Effectiveness and Clinical Outcomes Using Three Methods
Lead sponsor
Canadian Diabetes Association
Phase
Observational
Overall status
Completed
Start date
January 31, 2001
Completion date
September 30, 2004
Enrollment
5,800
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes